Broadcom

Oracle

Costco

Smyrna, Delaware — August 28, 2026 (GLOBE NEWSWIRE) — AiRWA Inc. (NASDAQ: YYAI) (the "Company") today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on August 24, 2026 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1)

SARASOTA, Fla.—August 28, 2026— Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biopharmaceutical company developing brain-targeted therapeutics through its proprietary intranasal delivery platform, today provided an update on its Phase IIa clinical trial, U.S. regulatory pathway, and NYSE American continued listing status.

On August 24, 2026, Socket Mobile, Inc. (the "Company") received a letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital

On August 28, 2026, Spero Therapeutics, Inc., a Delaware corporation (the "Company"), entered into an Open Market Sale Agreement℠ (the "Sale Agreement") with Jefferies LLC, as agent ("Jefferies"), pursuant to which the Company may offer and sell shares (the "Shares") of its common stock, $0.001 par value per share (the "Common Stock"), from time to time through Jefferies (the "Offering").

As previously announced, on June 22, 2026, Boundless Bio, Inc., a Delaware corporation ("Boundless Bio"), Boulder Merger Sub Corp., a Delaware corporation and wholly owned subsidiary of Boundless Bio ("Merger Sub"), and Serapha Bio, Inc., a Delaware corporation ("Serapha"), entered into an Agreement and Plan of Merger and Reorganization (as amended, the "Merger Agreement"), pursuant to which Merger Sub will be merged with and into Serapha, with Serapha surviving as a wholly owned subsidiary of Boundless Bio (the "Merger" and, together with all of the other transactions contemplated by the Merger Agreement, the "Contemplated Transactions").

On August 28, 2026, Mobix Labs, Inc. (the "Company") issued to Leviston Resources, LLC ("Leviston") a senior secured convertible promissory note in the original principal amount of $1,200,000 (the "Convertible Note") for a purchase price of $1,000,000, and has been issued pursuant to an investor rights agreement dated August 28, 2026 by and between the Company and Leviston

The information contained under Item 2.03 below is hereby incorporated by reference into this Item 1.01

Statement shall include (a) the difference between (I) the number of shares of Common Stock issued and issuable upon conversion of the Initial Notes at the Initial Conversion Price and (II) the number of shares of Common Stock issued and issuable upon conversion of the Initial Notes at the Floor Price, (b) the number of shares of Common Stock issued or issuable upon conversion of the Second Notes at the Floor Price and (c) the number of shares of Common Stock issued or issuable upon exercise of the Second Warrants; and (vi) carve out from the liquidated damages provisions set forth in the Registration Rights Agreement liquidated damages associated with the Company's failure to file the…

On August 28, 2026, Polar Power, Inc. (the " Company ") issued two convertible promissory notes, in an aggregate principal amount of $165,000 (the " Note "), to LU2 Holdings LLC and CL Investment Group LLC for aggregate consideration of $150,000.

Comment for Type of Reporting Person: The number of shares beneficially owned as reported in Rows (7), (9) and (11) includes 202,117,241 Ordinary Shares of Lufax convertible from the Notes, as defined in Item 6 below.

IN Comment for Type of Reporting Person: With respect to rows 7, 9, and 11 immediately above, the aggregate amount of shares beneficially owned by Kouji Eguchi reflects (i) 1,797,515 Common Shares, no par value per share (the "Common Shares"), of the Issuer held by Mr. Eguchi, (ii) 22,543 American Depositary Shares of the Issuer, each representing one Common Share (the "ADSs"), held by COZY LLC, a limited liability company (godo kaisha) organized under the laws of Japan that is wholly owned and controlled by Mr. Eguchi ("COZY"), (iii) an aggregate of 186,500 Common Shares that may be issued upon exercise of stock options held by Mr.

Item 4 of the Schedule 13D is hereby amended and supplemented to include the following: The transactions described in this Amendment No. 11 were undertaken solely to effect an internal reorganization of the PPF group of companies. Such transactions did not involve any change in the ultimate beneficial ownership of, or the ultimate voting or dispositive power over, the Ordinary Shares reported herein, and were not undertaken with any purpose of, or with the effect of, changing or influencing control of the Issuer.

Item 4 of Schedule 13D of the Securities Exchange Act of 1934 (the "Act"). However, each such person reserves the right to propose or participate in future transactions which may result in one or more of such actions. In addition, consistent with their investment purpose, such persons may engage in communications with persons associated with the Issuer, including stockholders of the Issuer, officers of the Issuer and/or members of the board of directors of the Issuer, to discuss matters regarding the Issuer, including but not limited to its operations and strategic direction. Until the date on which this Schedule 13D was filed with the SEC, Mr.

Item 1 Comment: This Amendment No. 3 (this "Amendment No. 3" or this "Schedule 13D/A") amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on June 30, 2021 and amended on June 4, 2026 and June 30, 2026 (as amended, the "Statement") by the Reporting Persons. Unless otherwise defined herein, capitalized terms used in this Amendment No. 3 shall have the meanings ascribed to them in the Statement. Unless amended or supplemented below, the information in the Statement remains unchanged.

Item 4. Is supplemented by adding the following: The Report Person intends to review its investment in the Issuer on a continuing basis and depending upon various factors, including without limitation, the Issuer's financial position and strategic direction, overall market conditions, the need for diversification and other investment opportunities available to the Reporting Person, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, the Reporting Person may endeavor (i) to increase or decrease its position in the Issuer through, among other things, the purchase or sale of securities of the Issuer, including through…

The securities of the Issuer acquired by the Reporting Persons and Reporting Entity were disposed of in connection with the administration of the estate of Charles C. Anderson. Depending upon market conditions and other factors that each of the Reporting Persons and the Reporting Entity may deem material to his or its investment decision, such Reporting Person or Reporting Entity may make purchases of Common Stock from time to time and may dispose of any or all of the shares of Common Stock held by him or it at any time.

The Reporting Person involved in the securities described in this Schedule 13D in connection with the Spin-Off Distribution, and intends to review its investment in the Issuer on a continuing basis. The Reporting Person may from time to time acquire additional securities of the Issuer, or retain or sell all or portion of the shares then held by the Reporting Person, in the open market, block trades, underwritten public offerings or privately negotiated transactions.

Item 4 of the Schedule 13D is hereby supplemented as follows: The responses set forth in Items 1, 2, 3, 5 and 6 hereof are incorporated by reference in their entirety.

Item 4 of the Original Schedule 13D is hereby amended and supplemented to add the following: As described in Item 5, as a result of the issuance by the Issuer of additional shares of Common Stock, and not as a result of any acquisition or disposition of securities by the Reporting Person, the Reporting Person ceased to be the beneficial owner of more than five percent of the outstanding Common Stock on August 18, 2026. Accordingly, this Amendment constitutes the final amendment to the Schedule 13D, and the Reporting Person's reporting obligations under Section 13(d) of the Act with respect to the Common Stock are terminated.

The reporting persons are filing this Schedule 13D pursuant to rule 13d-1(f) because the Fund's beneficial ownership of the Issuer's Class A Ordinary Common Stock ("Stock") exceeds 20% of that class effective as of August 27, 2026. The reporting persons have not, however, acquired any securities of the Issuer with the purpose or effect of changing or influencing control of the Issuer, or in connection with or as a participant in any transaction having that purpose or effect. The reporting persons acquired shares of the Stock for investment purposes based on their belief that the Stock, when purchased, was undervalued and represented an attractive investment opportunity.

In connection with estate planning, entities owned by trusts created for the benefit of Dr. Jonathan Rothberg's children have entered into a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the "Plan"), a copy of which is attached hereto as Exhibit 6. Pursuant to the Plan, sales of up to 8,947,746 shares of Class A common stock may be effected during the plan sales period beginning following the cooling-off period contained in Rule 10b5-1(c) on January 15, 2027 and ending on January 15, 2028 in accordance with the terms and conditions of the Plan.

The Purchased Shares were acquired by the Reporting Persons for investment purposes, and such purchases were made in the ordinary course of business of the Reporting Persons.

Lianyi Holding Limited is a shipping services company, with its principal business address at RM 604, 6/F, Wing On Plaza, No. 62 Mody Road, Tsim Sha Tsui East, Kowloon, Hong Kong. Yu Chen serves as a Director of Lianyi Holding Limited, whose principal business and address are set forth above.

Item 5.02 of the Original Form 8-K in its entirety. Except as expressly set forth herein, this Amended Form 8-K does not amend, update or otherwise modify any other disclosure contained in the Original Form 8-K .

Watchlist — filings

Your own filing stream